AuraSense Therapeutics grabs over $18 mln

Biopharmaceutical company AuraSense Therapeutics has raised over $18 million in Series C funding. The investors in this round were not named.

5 February 2015•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.